The Stock Price of UnitedHealth Group Still Falls More Than 30% from Two Years Ago, and Policy Dependency Becomes a Key Investment Consideration Jun 12, 2026 Life Science
RVMD Skyrockets 285% in a Year on Historic Pancreatic Cancer Drug Breakthrough Jun 11, 2026 Life Science
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year Jun 11, 2026 Life Science
Market Embraces R&D Pipeline Progress, Moderna’s Stock Soars on Cancer Vaccine Prospects Jun 9, 2026 Life Science
The Economic Outlook Clouds Over, Weighing on the Market, but Two Pharmaceutical Giants May Buck the Trend Jun 8, 2026 Life Science
Double Victory for Eli Lilly: Superior Weight-Loss Data & Bold Vaccine Expansion Jun 8, 2026 Life Science
RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy? Jun 5, 2026 Life Science
Strong Demand for GLP-1 Drugs Drives Eli Lilly’s Leadership with New Oral Medication and Acquisitions Jun 4, 2026 Life Science
Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities Jun 4, 2026 Life Science
Gene Editing Could Become the Next “Golden Rush” in the Pharmaceutical Industry, What Does This Mean for CRISPR Therapeutics? Jun 3, 2026 Life Science
Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge Jun 3, 2026 Life Science
AbbVie Faces a Challenger in Johnson & Johnson, but Investors Need Not Panic Jun 3, 2026 Life Science
